Similarly, as the PI3K-AKT is a well-known pathway for cell growth, tumorigenesis and cancer-related angiogenesis30, it is not surprising that the PI3K inhibitor LY294002 hampered the angiogenic phenotypes of endothelial cells in this study. This evidence concerns the gene AKT1 and cancer.